13F Holdings
中文EN

HCMC Healthier Choices Management Corp.

Tobacco Products · OTC · SEC CIK 844856 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-18.8%
TTM net income YoY35.7%
TTM EPS YoY—
Revenue 3-yr CAGR-96.6%
Net income 3-yr CAGR—

Margins

Gross margin-13,234.5%
Operating margin-1,697,351.3%
Net margin-2,373,421.8%
FCF margin-739,084.6%
EBITDA margin-1,684,323.4%

Returns

ROE-457.6%
ROA-71.7%
ROIC (approx.)-344.1%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets120.3%
Debt / equity—
Current ratio0.73x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.31x
Accruals ratio-49.6%
Payout ratio—
Capex / revenue9,418.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2,979$501$617$29.27M$13.32M
Cost of revenue$30,920$66,806$787——
Gross profit-$27,941-$66,305-$170$10.22M$5.29M
SG&A expense—$1.00M$32.22M$18.88M$10.03M
Operating income-$7.03M-$8.50M-$7.45M-$8.65M-$4.74M
Interest expense————$65,281
Income tax———$0$0
Net income-$7.02M-$11.89M-$18.48M-$7.22M-$4.04M
EBITDA-$6.99M-$8.44M-$5.96M-$7.59M-$4.24M
EPS (basic)——0.000.000.00
EPS (diluted)——0.000.000.00
Weighted avg. shares (diluted)481.27B479.70B429.92B339.74B307.91B
Banking
Net interest income$34,741$126,000$411,677$202,653—
Balance sheet
Cash & equivalents$1.14M$1.19M$3.66M$24.69M$26.50M
Short-term investments———$9,771$23,143
Receivables$199—$128,171$55,815$28,481
Inventory$36,148$40,460$66,671$3.82M$1.52M
Current assets$1.34M$1.95M$11.73M$30.31M$28.77M
PP&E, net$7,789$80,541$58,613$3.11M$176,988
Goodwill———$5.75M$916,000
Intangibles$119,026$158,151$198,163$5.01M$947,593
Total assets$1.47M$2.22M$30.97M$55.26M$34.44M
Current liabilities$1.59M$2.67M$12.23M$9.91M$2.52M
Short-term debt——$1.16M$536,542$2,604
Long-term debt——$2.40M$2.38M$815
Total debt——$3.56M$2.91M$3,419
Total liabilities$1.59M$2.67M$23.10M$20.33M$5.21M
Shareholders' equity-$1.23M-$1.56M$6.76M$20.21M$29.23M
Net debt——-$98,766-$21.78M-$26.49M
Shares outstanding525.16B481.27B478.27B339.74B339.74B
Cash flow statement
Operating cash flow-$3.88M-$3.66M-$4.74M-$3.87M-$3.53M
Capital expenditure—$47,185$184,349$480,925$56,418
Free cash flow—-$3.70M-$4.92M-$4.35M-$3.58M
Investing cash flow—-$4.92M-$768,555-$10.73M-$87,322
Financing cash flow$3.37M$4.69M-$13.55M$12.79M$27.19M
Depreciation & amortization$47,817$65,270$1.49M$1.06M$497,408
Stock-based compensation$3.40M$4.62M$3.43M$72,222$34,375

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.